According to reports, the US Food and Drug Administration (FDA) turned down Neuralink’s application to implant a chip in a human brain due to safety concerns.
After testing it on pigs and monkeys, Elon Musk said in December of last year that his brain-computer Neuralink device was ready for human trials and that he anticipated doing so in roughly six months.
According to recent reports from Reuters, the FDA turned down Neuralink’s request for a human experiment due to a number of safety issues, including doubts about the implant’s small wires and lithium-ion battery and the device’s ability to be removed without harming brain tissue.
The story quoted Neuralink employees as saying that the company was still addressing the agency’s issues a year after the rejection.
Most of the paperwork required for a human clinical trial had already been submitted to the US FDA by Neuralink.
The new Twitter CEO had stated, “We are now confident that the Neuralink device is ready for humans, so timing is a function of working through the FDA-approval process.”
The objective of Neuralink is to develop a brain implantable device that will enable brain activity to control a computer.
Small and flexible “threads” that can be placed into the brain are part of the Neuralink devices.
For lack of a better comparison, Musk remarked, “It’s like replacing a piece of your skull with a smartwatch.”
According to him, as time goes on, the device can be updated.
Musk has said that the implant from Neuralink, which records and stimulates brain activity, may help individuals deal with diseases like obesity.
Musk predicts that Neuralink brain chips will one day make people extremely clever and enable paralysed people to regain their ability to move.
READ MORE : Elon Musk accused of ruining peaceful village